SCHEMBL108509

SCHEMBL108509

O=C(Cl)c1cccc(C(F)(F)F)c1Cl

nearest known ligand 0.54

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CTSS P25774 3/20 0.54
CTSK P43235 2/20 0.51
P2RX7 Q99572 16/20 0.49
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28311763 0.86 CTSS (0.55) CTSSCTSKP2RX7LMNAGAA
SCHEMBL422330 0.85 TSHR (0.57) CTSSCTSKP2RX7LMNAGAA
SCHEMBL16127683 0.85 CTSS (0.57) CTSSCTSKP2RX7LMNAGAA
SCHEMBL324095 0.83 CTSS (0.57) CTSSCTSKP2RX7LMNAGAA
SCHEMBL3185133 0.83 CTSS (0.52) CTSSCTSKP2RX7LMNAGAA
SCHEMBL9524633 0.83 CTSS (0.56) CTSSCTSKP2RX7LMNAGAA
Hydrochloric Acid SCHEMBL2990630 0.83 TSHR (0.55) CTSSCTSKP2RX7LMNAGAA
SCHEMBL9637140 0.83 CTSS (0.52) CTSSCTSKP2RX7LMNAGAA
SCHEMBL29542921 0.83 CTSS (0.57) CTSSCTSKP2RX7LMNAGAA
SCHEMBL30562236 0.83 CTSS (0.56) CTSSCTSKP2RX7LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107567439-A The ketone derivatives of 2 homopiperazine, 1 base 4H, 1,3 benzothiazines 4 and the method for preparing the keto hydrochloride of 2 1,3 benzothiazine of (height) piperazine 4 洛桑联邦理工学院 2018-01-09 CN claimed
CN-107488146-A ICD derivative and its preparation method and application 中国科学院兰州化学物理研究所 2017-12-19 CN claimed
US-12590087-B2 Inhibiting USP36 VALO HEALTH, INC. (US) 2026-03-31 US disclosed
US-12338243-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2025-06-24 US disclosed
US-12247027-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2025-03-11 US disclosed
CN-114222574-B Inhibition of USP36 瓦洛健康股份有限公司 2024-12-17 CN disclosed
US-20240116930-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-04-11 US disclosed
US-11820770-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-11820770-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-11820770-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
CN-115894452-A P2X7 receptor inhibitor 四川大学 2023-04-04 CN disclosed
CN-1553828-A Generation of ion exchanger media ��Ĭɭ�����ѧ���޹�˾ 2004-12-08 CN disclosed
CN-1384743-A Remedies or preventives for diseases in association with chemokines TEIJIN LTD (JP) 2002-12-11 CN disclosed
CN-1362954-A Sulfamidohydroxamic acid metalloprotease inhibitor SEARLE & CO (US) 2002-08-07 CN disclosed
CN-1295677-A Method and apparatus for accelerated orthokeratology EASTA PHARMACEUTICALS INC (US) 2001-05-16 CN disclosed
CN-1284165-A Method and reagents for quantification of solid-phase reactions using fluorine NMR AVENTISS PHARMACEUTICAL PRODUC (US) 2001-02-14 CN disclosed
CN-1226803-A Diphenyl heterocycles as potassium channel modulators BRISTOL MYERS SQUIBB CO (US) 1999-08-25 CN disclosed
CN-1043835-C Bactericide for preventing and treating plant take-all disease MONSANTO CO (US) 1999-06-30 CN disclosed
CN-1100261-A Herbicides RHONE POULENC AGRICULTURE (GB) 1995-03-22 CN disclosed
CN-1058880-A The sulfoneoxime ester compound of tool Fungicidally active DU PONT (US) 1992-02-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12247027-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 CTSS 2569/4885CTSK 1661/4885P2RX7 2/4885
US-12338243-B2 P2X7 modulators P2RX7, P2RX4, P2RX1 CTSS 2298/4885CTSK 1472/4885P2RX7 1/4885
US-11820770-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 CTSS 2569/4885CTSK 1661/4885P2RX7 2/4885
US-20240116930-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 CTSS 2569/4885CTSK 1661/4885P2RX7 2/4885
US-12590087-B2 Inhibiting USP36 USP36, USP39, USP30 CTSS 2261/4885CTSK 2409/4885P2RX7 4648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.